Vern Kornelsen - Encision Independent Director

ECIADelisted Stock  USD 0.46  0.00  0.00%   

Director

Mr. Vern D. Kornelsen serves as an Independent Director of Encision Inc. He is one of Company cofounders and served on Company board of directors and as Company Chief Financial Officer from 1991 through February 1997. He was reelected to the board of directors in April 1998. Mr. Kornelsen is the General Partner of CMED Partners LLLP, one of principal shareholders. Mr. Kornelsen formerly practiced as a certified public accountant in the state of Colorado for many years. He was active in managing two investment partnerships, the first since 1990 and the second since 1997, of which he is the general partner, as well as serving as an officer and director of several private companies and of one public company, Lifeloc Technologies, Inc., of which he is the controlling stockholder since 1998.
Age 90
Tenure 26 years
Phone303 444 2600
Webhttps://www.encision.com
Kornelsen received a BS degree in business from the University of Kansas.

Encision Management Efficiency

The company has return on total asset (ROA) of (0.0831) % which means that it has lost $0.0831 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2203) %, meaning that it created substantial loss on money invested by shareholders. Encision's management efficiency ratios could be used to measure how well Encision manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 206 K in liabilities with Debt to Equity (D/E) ratio of 0.35, which is about average as compared to similar companies. Encision has a current ratio of 3.19, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Encision until it has trouble settling it off, either with new capital or with free cash flow. So, Encision's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Encision sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Encision to invest in growth at high rates of return. When we think about Encision's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Marcus FramptonScientific Industries
38
Paul KudelkoProcyon
74
James AndersonProcyon
53
Michael MaloneEnvironmmtl Tectonic
73
Edward UngarSCI Engineered Materials
79
H LenfestEnvironmmtl Tectonic
81
Linda BrentEnvironmmtl Tectonic
59
Winston ScottEnvironmmtl Tectonic
63
Laura ShunkSCI Engineered Materials
58
Roger ColleyEnvironmmtl Tectonic
74
George AndersonEnvironmmtl Tectonic
65
Michael FoleyProcyon
76
Roger KnowlesScientific Industries
89
Fred SuggsProcyon
67
George SawyerEnvironmmtl Tectonic
80
James SegastureScientific Industries
81
John GilliamSCI Engineered Materials
N/A
Joseph TreshlerProcyon
61
Charles WickershamSCI Engineered Materials
N/A
Grace MorinScientific Industries
69
Robert PeitzSCI Engineered Materials
54
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado. Encision operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 31 people. Encision [ECIA] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). Encision is listed under Medical Equipment category by Fama And French industry classification.

Management Performance

Encision Leadership Team

Elected by the shareholders, the Encision's board of directors comprises two types of representatives: Encision inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Encision. The board's role is to monitor Encision's management team and ensure that shareholders' interests are well served. Encision's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Encision's outside directors are responsible for providing unbiased perspectives on the board's policies.
Brad Greathouse, Vice President - Regulatory Affairs & Quality Assurance
Michael Biggs, VP of Engineering
Peter Geary, Vice President - Operations
Mala Ray, Controller, Treasurer and Corporate Secretary
Gregory Trudel, CEO and President and Director
Valerie Ray, VP of Operations
Brian Jackman, VP Marketing
Robert Fries, Independent Director
Ruediger NaumannEtienne, Independent Director
Patrick Pace, Executive Chairman of the Board
David Newton, Co-Founder, VP of Technology and Director
Vern Kornelsen, Independent Director

Encision Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Encision a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Encision

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Encision position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Encision will appreciate offsetting losses from the drop in the long position's value.

Moving against Encision Pink Sheet

  0.54RVP Retractable TechnologiesPairCorr
  0.49INFU InfuSystems Holdings Earnings Call This WeekPairCorr
The ability to find closely correlated positions to Encision could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Encision when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Encision - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Encision to buy it.
The correlation of Encision is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Encision moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Encision moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Encision can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Consideration for investing in Encision Pink Sheet

If you are still planning to invest in Encision check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Encision's history and understand the potential risks before investing.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Commodity Directory
Find actively traded commodities issued by global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance